Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Revue Neurologique|July 23, 2004
[Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers]J Devaux, C Beeton, E Béraud, et al.Anaesthesia|July 1, 1986
Plasma morphine levels produced by continuous infusion in childrenR J Bray, C Beeton, W Hinton, et al.Arthritis and Rheumatism|October 23, 2001
Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritisG Cunnane, O Fitzgerald, C Beeton, et al.Journal of Anatomy|August 13, 1999
Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilageA Horner, N J Bishop, S Bord, et al.Annals of the Rheumatic Diseases|August 15, 2001
Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controlsS A Young-Min, C Beeton, R Laughton, et al.Proceedings of the National Academy of Sciences of the United States of America|November 22, 2001
Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosisC Beeton, H Wulff, J Barbaria, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activationC Beeton, J Barbaria, P Giraud, et al.Molecular Pharmacology|January 6, 2009
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytesM W Pennington, C Beeton, C A Galea, et al.Pageof 1